Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andersson

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Journal of the National Cancer Institute|February 7, 2002
Lung cancer following chemotherapy and radiotherapy for Hodgkin's diseaseLois B Travis, Mary Gospodarowicz, Rochelle E Curtis, et al.
Journal of the National Cancer Institute|January 10, 2008
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trialPrudence Francis, John Crown, Angelo Di Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 studyGunter von Minckwitz, Andreas du Bois, Marcus Schmidt, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancerGunter von Minckwitz, Kathrin Schwedler, Marcus Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 yearsGraça M Dores, Catherine Metayer, Rochelle E Curtis, et al.
JAMA|July 24, 2003
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin diseaseLois B Travis, Deirdre A Hill, Graça M Dores, et al.
Journal of the National Cancer Institute|September 22, 2005
Second cancers among 40,576 testicular cancer patients: focus on long-term survivorsLois B Travis, Sophie D Fosså, Sara J Schonfeld, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE studyMarilyn Stovall, Susan A Smith, Bryan M Langholz, et al.
Biodiversity Data Journal|February 10, 2023
Contribution to the knowledge of Limoniidae (Diptera: Tipuloidea): first records of 244 species from various European countriesLevente-Péter Kolcsár, Pjotr Oosterbroek, Dmitry I Gavryushin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2017
Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized TrialBent Ejlertsen, Malgorzata K Tuxen, Erik Hugger Jakobsen, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|February 7, 2002
Lung cancer following chemotherapy and radiotherapy for Hodgkin's diseaseLois B Travis, Mary Gospodarowicz, Rochelle E Curtis, et al.
Journal of the National Cancer Institute|January 10, 2008
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trialPrudence Francis, John Crown, Angelo Di Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 studyGunter von Minckwitz, Andreas du Bois, Marcus Schmidt, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancerGunter von Minckwitz, Kathrin Schwedler, Marcus Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 yearsGraça M Dores, Catherine Metayer, Rochelle E Curtis, et al.
JAMA|July 24, 2003
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin diseaseLois B Travis, Deirdre A Hill, Graça M Dores, et al.
Journal of the National Cancer Institute|September 22, 2005
Second cancers among 40,576 testicular cancer patients: focus on long-term survivorsLois B Travis, Sophie D Fosså, Sara J Schonfeld, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE studyMarilyn Stovall, Susan A Smith, Bryan M Langholz, et al.
Biodiversity Data Journal|February 10, 2023
Contribution to the knowledge of Limoniidae (Diptera: Tipuloidea): first records of 244 species from various European countriesLevente-Péter Kolcsár, Pjotr Oosterbroek, Dmitry I Gavryushin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2017
Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized TrialBent Ejlertsen, Malgorzata K Tuxen, Erik Hugger Jakobsen, et al.
Pageof 10